IBRX
ImmunityBio, Inc. Common StockRecent alerts on IBRX
All signals →
News
ImmunityBio Stock Climbs As FDA Accepts Expanded Use Filing For Bladder Cancer Drug
13d ago
News
ImmunityBio rises as Anktiva label expansion undergoes FDA review
13d ago
News
ImmunityBio Says ANKTIVA Combo Outperformed Rival Bladder Cancer Therapies
13d ago
SEC filing
IBRX Signs Exclusive U.S. Agreement with Japan BCG Laboratory for Tokyo Strain BCG, Backed by Positive Phase III SWOG S1602 Trial Results
14d ago
News
ImmunityBio Expands Bladder Cancer Arsenal With Exclusive Japanese BCG Partnership
15d ago
News
ImmunityBio acquiring U.S. rights to Tokyo strain of BCG
16d ago
News
Semiconductor materials and biotech stocks drive mid‑cap YTD rally
18d ago
SEC filing
IBRX Reports $44.2M Net Product Revenue, +168% YoY; $380.9M Cash; ANKTIVA Expands to 5 Jurisdictions, BCG-Naïve Trial Enrolled, NCCN Guideline Update
26d ago
News
Avis Brings Back The Short Squeeze — Navitas, Beyond Meat Join In
41d ago
News
FDA Flags Anktiva Claims While ImmunityBio Pushes Regulatory Fixes
56d ago
News
ImmunityBio Plunges After Getting FDA Warning on Cancer Drug
70d ago
News
Why ImmunityBio Stock Is Up More Than 11% Today
70d ago
News
ImmunityBio Stock Jumps As New Bladder Cancer Guideline Boosts Anktiva Use
76d ago
News
ImmunityBio gains as NCCN guidelines include new Anktiva indication
77d ago
News
ImmunityBio rises after updates on cell therapy programs
80d ago
News
Why Is ImmunityBio Stock Soaring On Friday?
81d ago
News
ImmunityBio Q4 2026 Earnings Preview
91d ago
Insider trade
Sale by Simon Barry J.
95d ago
News
ImmunityBio Investors Rally Behind Cancer Trial Milestone
95d ago
News
ImmunityBio GAAP EPS of -$0.06, revenue of $38.2M
99d ago
News
Stock Market Today, Feb. 18: ImmunityBio Soars After EU Approves ANKTIVA for Bladder Cancer
103d ago
SEC filing
IBRX Announces EC Conditional Authorization for ANKTIVA+BCG in NMIBC CIS, 71% CR, 33 Countries
104d ago
Insider trade
Sale by Christobel Selecky
104d ago
Insider trade
Sale by Simon Barry J.
104d ago
News
New Treatment Modalities Are Reaching Cancers That Resisted Everything Else
104d ago
Get push alerts for IBRX
Add it to your watchlist in the app and receive every signal the moment it fires.
Download for iOS